GSA Capital Partners’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $935K | Buy |
760,448
+64,895
| +9% | +$79.8K | 0.07% | 504 |
|
|
2025
Q1 | $765K | Sell |
695,553
-166,860
| -19% | -$184K | 0.07% | 514 |
|
|
2024
Q4 | $780K | Buy |
862,413
+794,867
| +1,177% | +$719K | 0.06% | 574 |
|
|
2024
Q3 | $67K | Buy |
+67,546
| New | +$67K | 0.01% | 1510 |
|
|
2023
Q3 | – | Sell |
-484,822
| Closed | -$582K | – | 1650 |
|
|
2023
Q2 | $582K | Buy |
484,822
+459,346
| +1,803% | +$551K | 0.06% | 647 |
|
|
2023
Q1 | $32K | Sell |
25,476
-101,021
| -80% | -$127K | ﹤0.01% | 1414 |
|
|
2022
Q4 | $274K | Buy |
126,497
+85,228
| +207% | +$185K | 0.03% | 997 |
|
|
2022
Q3 | $494K | Buy |
41,269
+19,447
| +89% | +$233K | 0.07% | 579 |
|
|
2022
Q2 | $183K | Buy |
21,822
+2,115
| +11% | +$17.7K | 0.03% | 1093 |
|
|
2022
Q1 | $171K | Buy |
+19,707
| New | +$171K | 0.02% | 1209 |
|
|
2021
Q4 | – | Sell |
-10,578
| Closed | -$133K | – | 1555 |
|
|
2021
Q3 | $133K | Buy |
+10,578
| New | +$133K | 0.01% | 1296 |
|
|
2021
Q2 | – | Sell |
-38,506
| Closed | -$356K | – | 1418 |
|
|
2021
Q1 | $356K | Buy |
+38,506
| New | +$356K | 0.06% | 546 |
|
|
2020
Q4 | – | Sell |
-63,461
| Closed | -$788K | – | 1353 |
|
|
2020
Q3 | $788K | Buy |
63,461
+49,448
| +353% | +$614K | 0.13% | 178 |
|
|
2020
Q2 | $182K | Sell |
14,013
-22,088
| -61% | -$287K | 0.1% | 374 |
|
|
2020
Q1 | $366K | Buy |
+36,101
| New | +$366K | 0.09% | 346 |
|